Selected for "The World's Most Impactful Companies of 2026" by TIME Magazine
H.U. Group Holdings, Inc. announced its selection in "The World’s Most Impactful Companies of 2026,"… · 2026-05-14
H.U.グループホールディングス株式会社 News Releases
[Group News] H.U. POCkeT and IISHINBAN to Engage in Osteoporosis Prevention Effectiveness Verification Project in Three Municipalities in Fukuoka Prefecture
H.U. POCkeT Co., Ltd. (President and CEO: Satoru Isago), a consolidated subsidiary, and IISHINBAN Co… · 2026-07-02
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Fujirebio Obtains Manufacturing and Sales Approval for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
Fujirebio Inc., part of the H.U. Group, obtained regulatory approval for 'Fujinokuni HOPE OncoPanel,… · 2026-03-31
Announcement of the Recipients of the Reiwa 7th Fiscal Year Public Trust Fund for the Promotion of Clinical Laboratory Medicine Research "Koichiro Fujita Award," "Nozomi Osakai Award," and "Research Grant"
The Public Trust Fund for the Promotion of Clinical Laboratory Medicine Research has announced the r… · 2026-04-03
Fujirebio Europe N.V. Obtains CE Mark for in Vitro Diagnostic Medical Device to Measure pTau217 in Blood for Alzheimer's Disease Pathological Changes in Europe
Fujirebio Europe N.V., a subsidiary of Fujirebio Holdings Inc., has received CE Marking in Europe fo… · 2026-05-11
Announcement of the Recipients of the Reiwa 7th Fiscal Year Public Trust Fund for the Promotion of Clinical Laboratory Medicine Research "Koichiro Fujita Award," "Nozomi Osakai Award," and "Research Grant"
The Public Trust Fund for the Promotion of Clinical Laboratory Medicine Research has announced the r… · 2026-04-03
Named 'Supplier Engagement Leader,' the Highest Rating in CDP 2025 Supplier Engagement Rating
H.U. Group Holdings has been selected as a 'Supplier Engagement Leader,' the highest rating in the 2… · 2026-05-21
Fujirebio Obtains Approval for Hepatitis B Rapid Test Kit in The Gambia
Fujirebio has obtained approval for the Hepatitis B rapid test kit 'ESPLINE HBeAg-hs' in The Gambia.… · 2026-05-25
Announcement of the Recipients of the Reiwa 7th Fiscal Year Public Trust Fund for the Promotion of Clinical Laboratory Medicine Research "Koichiro Fujita Award," "Nozomi Osakai Award," and "Research Grant"
The Public Trust Fund for the Promotion of Clinical Laboratory Medicine Research has announced the r… · 2026-04-03
Selected for the "SOMPO Sustainability Index" for the Sixth Consecutive Year
SOMPO Asset Management has been selected for the "SOMPO Sustainability Index" for the sixth consecut… · 2026-06-11
Fujirebio Europe N.V. Obtains CE Mark for in Vitro Diagnostic Medical Device to Measure pTau217 in Blood for Alzheimer's Disease Pathological Changes in Europe
Fujirebio Europe N.V., a subsidiary of Fujirebio Holdings Inc., has received CE Marking in Europe fo… · 2026-05-11
Approval of Manufacturing and Marketing for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system… · 2026-03-31
Fujirebio Obtains Manufacturing and Sales Approval for Cancer Gene Testing System 'Fujinokuni HOPE OncoPanel'
Fujirebio Inc., part of the H.U. Group, obtained regulatory approval for 'Fujinokuni HOPE OncoPanel,… · 2026-03-31
Selected for "The World's Most Impactful Companies of 2026" by TIME Magazine
H.U. Group Holdings, Inc. announced its selection in "The World’s Most Impactful Companies of 2026,"… · 2026-05-14